Year Established :
1998
Total Assets(USD) :
9,000,000 to 9,999,999
Total Number of Staff :
more than 500
Other Competitive Advantages :
R&D,
Production,
US FDA approved,
PMDA approved,
Chinese GMP approved.
Patents and Copyrights :
Famciclovir,
Candesartan,
Duloxetine,
etc.
Business Type :
Manufacturer,Trading Company,Service Provider
Annual Turnover(USD) :
35,000,000 to 39,999,999
Main Sales Markets :
Eastern Europe,Australasia,Asia
Main Product Categorise :
Active Pharmaceutical Ingredients,Intermediates,Excipients,Fine Chemicals,Custom Manufacturing
Product Range :
Treating Primary hypertension;
Antipsychotic used to treat schizophrenia and bipolar disorder;
Treatment symptoms of termor, bradykinesia, rigidity, postural instability
of parkinson´s disease and treating symptoms of neurogenic orthostatic hypotensi